Characterization of the novel heterozygous SCN5A genetic variant Y739D associated with Brugada syndrome

Genetic variants in SCN5A gene were identified in patients with various arrhythmogenic conditions including Brugada syndrome. Despite significant progress of last decades in studying the molecular mechanism of arrhythmia-associated SCN5A mutations, the understanding of relationship between genetics,...

Full description

Bibliographic Details
Main Authors: Anastasia K. Zaytseva, Artem M. Kiselev, Alexander S. Boitsov, Yulia V. Fomicheva, Georgii S. Pavlov, Boris S. Zhorov, Anna A. Kostareva
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Biochemistry and Biophysics Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405580822000498
_version_ 1818554413886734336
author Anastasia K. Zaytseva
Artem M. Kiselev
Alexander S. Boitsov
Yulia V. Fomicheva
Georgii S. Pavlov
Boris S. Zhorov
Anna A. Kostareva
author_facet Anastasia K. Zaytseva
Artem M. Kiselev
Alexander S. Boitsov
Yulia V. Fomicheva
Georgii S. Pavlov
Boris S. Zhorov
Anna A. Kostareva
author_sort Anastasia K. Zaytseva
collection DOAJ
description Genetic variants in SCN5A gene were identified in patients with various arrhythmogenic conditions including Brugada syndrome. Despite significant progress of last decades in studying the molecular mechanism of arrhythmia-associated SCN5A mutations, the understanding of relationship between genetics, electrophysiological consequences and clinical phenotype is lacking. We have found a novel genetic variant Y739D in the SCN5A-encoded sodium channel Nav1.5 of a male patient with Brugada syndrome (BrS). The objective of the study was to characterize the biophysical properties of Nav1.5-Y739D and provide possible explanation of the phenotype observed in the patient. The WT and Y739D channels were heterologously expressed in the HEK-293T cells and the whole-cell sodium currents were recorded. Substitution Y739D reduced the sodium current density by 47 ± 2% at −20 mV, positively shifted voltage-dependent activation, accelerated both fast and slow inactivation, and decelerated recovery from the slow inactivation. The Y739D loss-of-function phenotype likely causes the BrS manifestation. In the hNav1.5 homology models, which are based on the cryo-EM structure of rat Nav1.5 channel, Y739 in the extracellular loop IIS1-S2 forms H-bonds with K1381 and E1435 and pi-cation contacts with K1397 (all in loop IIIS5-P1). In contrast, Y739D accepts H-bonds from K1397 and Y1434. Substantially different contacts of Y739 and Y739D with loop IIIS5-P1 would differently transmit allosteric signals from VSD-II to the fast-inactivation gate at the N-end of helix IIIS5 and slow-inactivation gate at the C-end of helix IIIP1. This may underlie the atomic mechanism of the Y739D channel dysfunction.
first_indexed 2024-12-12T09:39:10Z
format Article
id doaj.art-0767e6e17b27496b991e0a16f9540f31
institution Directory Open Access Journal
issn 2405-5808
language English
last_indexed 2024-12-12T09:39:10Z
publishDate 2022-07-01
publisher Elsevier
record_format Article
series Biochemistry and Biophysics Reports
spelling doaj.art-0767e6e17b27496b991e0a16f9540f312022-12-22T00:28:37ZengElsevierBiochemistry and Biophysics Reports2405-58082022-07-0130101249Characterization of the novel heterozygous SCN5A genetic variant Y739D associated with Brugada syndromeAnastasia K. Zaytseva0Artem M. Kiselev1Alexander S. Boitsov2Yulia V. Fomicheva3Georgii S. Pavlov4Boris S. Zhorov5Anna A. Kostareva6Almazov National Medical Research Centre, St. Petersburg, 197341, Russia; Sechenov Institute of Evolutionary Physiology & Biochemistry, Russian Academy of Sciences, St. Petersburg, 194223, Russia; Corresponding author. Almazov National Medical Research Centre, St. Petersburg, 197341, Russia.Almazov National Medical Research Centre, St. Petersburg, 197341, Russia; Institute of Cytology, Russian Academy of Sciences, Saint Petersburg, RussiaAlmazov National Medical Research Centre, St. Petersburg, 197341, RussiaAlmazov National Medical Research Centre, St. Petersburg, 197341, RussiaAlmazov National Medical Research Centre, St. Petersburg, 197341, RussiaAlmazov National Medical Research Centre, St. Petersburg, 197341, Russia; Sechenov Institute of Evolutionary Physiology & Biochemistry, Russian Academy of Sciences, St. Petersburg, 194223, Russia; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, L8S 4K1, CanadaAlmazov National Medical Research Centre, St. Petersburg, 197341, Russia; Department of Woman and Child Health, Karolinska Institute, Stockholm, 17176, SwedenGenetic variants in SCN5A gene were identified in patients with various arrhythmogenic conditions including Brugada syndrome. Despite significant progress of last decades in studying the molecular mechanism of arrhythmia-associated SCN5A mutations, the understanding of relationship between genetics, electrophysiological consequences and clinical phenotype is lacking. We have found a novel genetic variant Y739D in the SCN5A-encoded sodium channel Nav1.5 of a male patient with Brugada syndrome (BrS). The objective of the study was to characterize the biophysical properties of Nav1.5-Y739D and provide possible explanation of the phenotype observed in the patient. The WT and Y739D channels were heterologously expressed in the HEK-293T cells and the whole-cell sodium currents were recorded. Substitution Y739D reduced the sodium current density by 47 ± 2% at −20 mV, positively shifted voltage-dependent activation, accelerated both fast and slow inactivation, and decelerated recovery from the slow inactivation. The Y739D loss-of-function phenotype likely causes the BrS manifestation. In the hNav1.5 homology models, which are based on the cryo-EM structure of rat Nav1.5 channel, Y739 in the extracellular loop IIS1-S2 forms H-bonds with K1381 and E1435 and pi-cation contacts with K1397 (all in loop IIIS5-P1). In contrast, Y739D accepts H-bonds from K1397 and Y1434. Substantially different contacts of Y739 and Y739D with loop IIIS5-P1 would differently transmit allosteric signals from VSD-II to the fast-inactivation gate at the N-end of helix IIIS5 and slow-inactivation gate at the C-end of helix IIIP1. This may underlie the atomic mechanism of the Y739D channel dysfunction.http://www.sciencedirect.com/science/article/pii/S2405580822000498Brugada syndromeSodium channelSCN5ASodium channelopathiesHomology modeling
spellingShingle Anastasia K. Zaytseva
Artem M. Kiselev
Alexander S. Boitsov
Yulia V. Fomicheva
Georgii S. Pavlov
Boris S. Zhorov
Anna A. Kostareva
Characterization of the novel heterozygous SCN5A genetic variant Y739D associated with Brugada syndrome
Biochemistry and Biophysics Reports
Brugada syndrome
Sodium channel
SCN5A
Sodium channelopathies
Homology modeling
title Characterization of the novel heterozygous SCN5A genetic variant Y739D associated with Brugada syndrome
title_full Characterization of the novel heterozygous SCN5A genetic variant Y739D associated with Brugada syndrome
title_fullStr Characterization of the novel heterozygous SCN5A genetic variant Y739D associated with Brugada syndrome
title_full_unstemmed Characterization of the novel heterozygous SCN5A genetic variant Y739D associated with Brugada syndrome
title_short Characterization of the novel heterozygous SCN5A genetic variant Y739D associated with Brugada syndrome
title_sort characterization of the novel heterozygous scn5a genetic variant y739d associated with brugada syndrome
topic Brugada syndrome
Sodium channel
SCN5A
Sodium channelopathies
Homology modeling
url http://www.sciencedirect.com/science/article/pii/S2405580822000498
work_keys_str_mv AT anastasiakzaytseva characterizationofthenovelheterozygousscn5ageneticvarianty739dassociatedwithbrugadasyndrome
AT artemmkiselev characterizationofthenovelheterozygousscn5ageneticvarianty739dassociatedwithbrugadasyndrome
AT alexandersboitsov characterizationofthenovelheterozygousscn5ageneticvarianty739dassociatedwithbrugadasyndrome
AT yuliavfomicheva characterizationofthenovelheterozygousscn5ageneticvarianty739dassociatedwithbrugadasyndrome
AT georgiispavlov characterizationofthenovelheterozygousscn5ageneticvarianty739dassociatedwithbrugadasyndrome
AT borisszhorov characterizationofthenovelheterozygousscn5ageneticvarianty739dassociatedwithbrugadasyndrome
AT annaakostareva characterizationofthenovelheterozygousscn5ageneticvarianty739dassociatedwithbrugadasyndrome